|
| 1 |
Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers
Yongjun Cha, Sheehyun Kim, Sae-Won Han
|
|
| 2 |
Development of a Next-generation Sequencing-based Gene Panel Test to Detect Measurable Residual Disease in Acute Myeloid Leukemia
Jin Ju Kim, Ji Eun Jang, Hyeon Ah Lee, Mi Ri Park, Hye Won Kook, Seung-Tae Lee, Jong Rak Choi, Yoo Hong Min, Saeam Shin, June-Won Cheong
Ann Lab Med.2023;43(4):328-336. Published online 2023 February 24
DOI: http://dx.doi.org/10.3343/alm.2023.43.4.328
|
|
| 3 |
EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-Mutated NSCLC: A Prospective, Randomized, Exploratory Study
Weiguang Gu, Hua Zhang, Yiyu Lu, Minjing Li, Shuang Yang, Jianmiao Liang, Zhijian Ye, Zhihua Li, Minhong He, Xiaoliang Shi, Fei Wang, Dong You, Weiquan Gu, Weineng Feng
Cancer Res Treat.2023;55(3):841-850. Published online 2023 February 13
DOI: http://dx.doi.org/10.4143/crt.2022.1438
|
|
| 4 |
Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma
Hyun-Young Kim, In Young Yoo, Dae Jin Lim, Hee-Jin Kim, Sun-Hee Kim, Sang Eun Yoon, Seok Jin Kim, Duck Cho, Kihyun Kim
Ann Lab Med.2022;42(5):558-565. Published online 2022 September 1
DOI: http://dx.doi.org/10.3343/alm.2022.42.5.558
|
|
| 5 |
Minimal residual disease in acute lymphoblastic leukemia: technical aspects and implications for clinical interpretation
In-Suk Kim
Blood Res.2020;55(Supplement):S19-S26. Published online 2019 July 30
DOI: http://dx.doi.org/10.5045/br.2020.S004
|
|
| 6 |
Minimal residual disease in acute lymphoblastic leukemia: technical aspects and implications for clinical interpretation
In-Suk Kim
Blood Res.2020;55(S1):S19-S26. Published online 2019 July 30
DOI: http://dx.doi.org/10.5045/br.2020.S004
|
|
| 7 |
T-Cell Receptor Rearrangements Determined Using Fragment Analysis in Patients With T-Acute Lymphoblastic Leukemia
Hyerim Kim, In-Suk Kim, Chulhun L. Chang, Sun-Young Kong, Young Tak Lim, Seom Gim Kong, Eun Hae Cho, Eun-Yup Lee, Ho-Jin Shin, Hyeon Jin Park, Hyeon-Seok Eom, Hyewon Lee
Ann Lab Med.2019;39(2):125-132. Published online 2018 November 13
DOI: http://dx.doi.org/10.3343/alm.2019.39.2.125
|
|
| 8 |
Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia
Saeam Shin, In Sik Hwang, Jieun Kim, Kyung-A Lee, Seung-Tae Lee, Jong Rak Choi
Ann Lab Med.2017;37(4):331-335. Published online 2017 April 19
DOI: http://dx.doi.org/10.3343/alm.2017.37.4.331
|
|
| 9 |
Outcome and Prognostic Factors for ETV6/RUNX1 Positive Pediatric Acute Lymphoblastic Leukemia Treated at a Single Institution in Korea
Jae Wook Lee, Seong-koo Kim, Pil-Sang Jang, Nack-Gyun Chung, Dae-Chul Jeong, Myungshin Kim, Bin Cho, Hack-Ki Kim
Cancer Res Treat.2017;49(2):446-453. Published online 2016 August 10
DOI: http://dx.doi.org/10.4143/crt.2016.211
|
|
| 10 |
Measurements of treatment response in childhood acute leukemia
Dario Campana, Elaine Coustan-Smith
|
|
| 11 |
Minimal Residual Disease Detection in Acute Leukemia Patients by Flow Cytometric Assay of Cross-lineage Antigen Expression
Young-Uk Cho, Chan-Jeoung Park, Choong-Hwan Cha, Hyun-Sook Chi, Seongsoo Jang, Mi-Jung Kim, Kyoo-Hyung Lee, Je-Hwan Lee, Jung-Hee Lee, Jong Jin Seo, Ho Joon Im
|
|
| 12 |
Clinical Significance of Quantitation of WT1 Gene Expression for Minimal Residual Disease Monitoring of Acute Myelogenous Leukemia
Hye Ran Kim, Jeong Hwan Shin, Jeong Nyeo Lee, Eun Yup Lee
|
|
